10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

JOHNSON & JOHNSON

Ticker: JNJ   Fiscal Year: 2013

Consolidated Statements of Earnings

Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014)

(In Millions, except shares in Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 29, 2013Dec 30, 2012Jan 1, 2012
Sales to customers
$
71,312
67,22465,030
Cost of products sold22,34221,65820,360
Gross profit48,97045,56644,670
 
Selling, marketing and administrative expenses21,83020,86920,969
Research and development expense8,1837,6657,548
In-process research and development5801,1630
Interest income(74)(64)(91)
Interest expense, net of portion capitalized (Note 4)482532571
Other (income) expense, net2,4981,6262,743
Restructuring (Note 22)00569
Earnings before provision for taxes on income15,47113,77512,361
 
Provision for taxes on income (Note 8)1,6403,2612,689
Net earnings13,83110,5149,672
 
Add: Net loss attributable to noncontrolling interest03390
Net earnings attributable to Johnson & Johnson13,83110,8539,672
 
Net earnings per share attributable to Johnson & Johnson (Notes 1 and 15)
Basic4.923.943.54
Diluted4.813.863.49
Cash dividends per share2.592.402.25
Average shares outstanding (Notes 1 and 15)
Basic2,809,2002,753,3002,736,000
Diluted2,877,0002,812,6002,775,300
External Links 
JOHNSON & JOHNSON (JNJ) Fiscal Year 2013
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip